We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TOPSPIN MEDICAL GETS FDA APPROVAL TO START CLINICAL TRIALS IN THE US AND COMPLETES THE DEVELOPMENT OF A PROTOTYPE OF ITS ADVANCED GENERATION INTRAVASCULAR MRI (IVMRI) CATHETER
TOPSPIN MEDICAL GETS FDA APPROVAL TO START CLINICAL TRIALS IN THE US AND COMPLETES THE DEVELOPMENT OF A PROTOTYPE OF ITS ADVANCED GENERATION INTRAVASCULAR MRI (IVMRI) CATHETER
July 7, 2006
TopSpin Medical announced it has received FDA approval to start conducting clinical
trials in the US with its IntraVascular MRI (IVMRI) catheter, intended for the
characterization of lipid-rich lesions in the coronary arteries. TopSpin IVMRI
catheter technology enables MRI to be performed in the clinic for the first
time with no external magnets. To date the company conducted clinical trials
with its IVMRI catheter in more than 70 patients in Europe and Israel, and following
the FDA approval TopSpin intends to extend the clinical trials to leading US
clinical sites.
